Company news

Aclarion, Inc. news in 2022

Aclarion, Inc.'s news releases, calls and decks from 2022, newest first.

View company

Dr. Christopher Ames to Join Aclarion as a Key Opinion Leader Surgeon Advisor

December 21, 2022

Aclarion’s Key Opinion Leader Program Adds Fifth Surgeon Advisor with Addition of Eric Potts, MD

December 20, 2022

Aclarion Adds to Growing Key Opinion Leader Program with Juan Uribe M.D. as a Surgeon Advisor

December 18, 2022

Aclarion Adds to Strong Patent Portfolio with Notice of Allowance for New U.S. Patent Application Addressing Key Pain Indicator Biomarker

November 30, 2022

Dr. Sigurd Berven to join Aclarion as a Key Opinion Leader Surgeon Advisor

October 23, 2022

John Keller M.D. to Join Aclarion as a Key Opinion Leader Surgeon Advisor

October 2, 2022

Aclarion Announces Start of Healthcare Economic Analysis Study to Evaluate Financial Impact of Nociscan

July 19, 2022

Aclarion to Present 2-year Follow Up Data on Pivotal Clinical Trial Linking Nociscan to Better Surgical Outcomes for Discogenic Low Back Pain

June 21, 2022

Aclarion, Inc. Announces Closing of $9.4 Million Initial Public Offering

April 25, 2022

Decks in 2022